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Abstract: Objectives 
Non-pharmacological therapies are often recommended as a first line 
treatment for orthostatic hypotension (OH). However, the true effect of 
non-pharmacological therapy remains unclear, particularly in the older 
population. We undertook a systematic review evaluating the efficacy of 
non-pharmacological interventions in older people with OH to provide 
evidence-based recommendations.  
 
Design 
Systematic review of systematic reviews 
 
Setting and Participants 
MEDLINE, PubMed, EMBASE, and Cochrane Database of Systematic Reviews, 
CINHAL and PsychINFO were searched up to June 2018. Two reviewers 
identified eligible systematic reviews from which primary studies were 
selected. We included studies both randomized and non-randomized studies 
that evaluated any type of non-pharmacological intervention and reported 
outcomes of change in postural drop in systolic blood pressure (SBP) 
and/or orthostatic symptoms measured using any validated instrument. The 
Cochrane risk of bias tool was used, with recommendations based on the 
GRADE approach.  
 
Results 
Eleven trials were included. Meta-analysis of lower limb compression 
showed a reduction in the postural drop in SBP of 9.83 mmHg (95%CI -
12.56, -7.11), whereas abdominal compression showed a larger reduction in 
postural drop in SBP of 12.30mmHg (95%CI -18.20, -6.39). Compression 
therapy was also beneficial in reducing OH symptoms. However, the quality 
of the evidence for compression therapy was very poor. One study each was 
identified for sleeping-head-up (SHU), home based resistance training 
(HBRT) and multi-component intervention but did not significantly reduce 
postural SBP drop. Bolus water drinking was effective in one study but 
the study was of low quality.  
 
Conclusions/implications 
There is no high quality evidence to recommend any of the non-
pharmacological therapies for the management of OH in older people. Yet, 
we make a weak recommendation for lower limb and abdominal compression 
therapy based on very low quality evidence. Large-scale trials are 
warranted in older people to substantiate the efficacy of non-
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Non-pharmacological therapies are often recommended as a first line treatment for 3 
orthostatic hypotension (OH). However, the true effect of non-pharmacological therapy 4 
remains unclear, particularly in the older population. We undertook a systematic review 5 
evaluating the efficacy of non-pharmacological interventions in older people with OH to 6 
provide evidence-based recommendations.  7 
Design 8 
Systematic review of systematic reviews 9 
Setting and Participants 10 
MEDLINE, PubMed, EMBASE, and Cochrane Database of Systematic Reviews, CINHAL and 11 
PsychINFO were searched up to June 2018. Two reviewers identified eligible systematic 12 
reviews from which primary studies were selected. We included studies both randomized 13 
and non-randomized studies that evaluated any type of non-pharmacological intervention 14 
and reported outcomes of change in postural drop in systolic blood pressure (SBP) and/or 15 
orthostatic symptoms measured using any validated instrument. The Cochrane risk of bias 16 
tool was used, with recommendations based on the GRADE approach.  17 
Results 18 
Eleven trials were included. Meta-analysis of lower limb compression showed a reduction in 19 
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the quality of the evidence for compression therapy was very poor. One study each was 23 
identified for sleeping-head-up (SHU), home based resistance training (HBRT) and multi-24 
component intervention but did not significantly reduce postural SBP drop. Bolus water 25 
drinking was effective in one study but the study was of low quality.  26 
Conclusions/implications 27 
There is no high quality evidence to recommend any of the non-pharmacological therapies 28 
for the management of OH in older people. Yet, we make a weak recommendation for lower 29 
limb and abdominal compression therapy based on very low quality evidence. Large-scale 30 
trials are warranted in older people to substantiate the efficacy of non-pharmacological 31 





Orthostatic hypotension (OH) is extremely common in older people and increases with 34 
advancing age1. An International consensus statement defined OH as a sustained reduction 35 
in systolic blood pressure of at least 20 mmHg or diastolic blood pressure of 10 mmHg 36 
within 3 minutes of standing or head-up tilt to at least 60° on a tilt table2. Prevalence of OH 37 
varies greatly, from 5% to70% depending on the setting or population3,4.  Saedon et al. 38 
reported that the pooled prevalence of OH was 22.2% and 23.9% in community dwelling 39 
older people and in long-term care settings respectively5. A cross-sectional cohort study 40 
involving 653 home-dwelling people aged 75 years and above reported an OH prevalence of 41 
34%6. In addition to ageing, polypharmacy is also associated with increased prevalence of 42 
OH, being reported in up to 65% of veterans attending a geriatrics clinic7. 43 
Medications that increase the risk of OH include vasodilators, antihypertensives, β-blockers, 44 
calcium antagonists, renin-angiotensin inhibitors, α-blockers, dopaminergic agents, 45 
antipsyhotics, antidepressants and sedative-hypnotics8-12. OH is significantly associated with 46 
coronary heart disease, heart failure, transient ischaemic attacks, isolated systolic 47 
hypertension, and carotid stenosis1,13-15. The annual rate of OH-related hospitalizations, 48 
from a nationwide inpatient sample in 2004 was 36 per 100,000 US adults which increased 49 
to 233 per 100,000 in patients aged 75 years or older. OH was the primary diagnosis in 35% 50 
of these hospitalizations16. Additionally, OH is an independent risk factor for falls1,17,18 and 51 
all-cause mortality17,19. In the Atherosclerosis Risk in Communities cohort study, all-cause 52 
mortality was 13.7% in those with OH compared to 4.2% in those without20.   53 
The main goal in the treatment of OH is to alleviate the postural symptoms and improve 54 




The first step in OH treatment involves considering discontinuing or reducing dose of any 56 
medications that could potentially cause OH23. Non-pharmacological interventions are the 57 
first line of treatment for OH and pharmacological treatments are introduced only in severe 58 
cases of OH where non-pharmacological treatment is inadequate17,21,24-26. Although 59 
guidelines exist for managing OH, optimal non-pharmacological management is not well 60 
defined for the geriatric population.  Indeed, the effectiveness of non-pharmacological 61 
treatment has been questioned27. There is a significant lack of research evidence in the fast 62 
growing population of older people with OH. Hence, we set out to fill this evidence gap as 63 
part of the SENATOR-ONTOP work package (Software ENgine for the assessment and 64 
Optimization of drug and non-drug Therapy in Older peRsons-Optimal Evidence-Based Non-65 
drug Therapies in Older People)28 with the view of development of evidence based 66 
recommendations for the non-pharmacological interventions for common geriatric 67 
conditions.  68 
The aim was to assess the efficacy of non-pharmacological interventions in the treatment of 69 
OH in people aged ≥65 years.  70 
Methods 71 
This review of systematic reviews was conducted according to the SENATOR-ONTOP 72 
protocol29. A literature search was undertaken on EMBASE, PubMed, the Cochrane 73 
Database of Systematic Reviews (CDSR), CINAHL, and PsycINFO from inception to 6th June 74 
2018 to identify systematic reviews. Key search terms used included orthostatic 75 
hypotension, postural hypotension, orthostasis, orthostatic intolerance, orthostatic syncope 76 
and postural blood pressure.  There was no language restriction, however authors planned 77 




restricted to 'human only' studies and publication type was limited to 'systematic 79 
review/reviews/meta-analysis'.  80 
Study selection criteria  81 
We included systematic reviews and/or review articles that had evaluated any non-82 
pharmacological intervention for treatment of OH, used at least one medical literature 83 
database for evidence searching, included at least one primary study, and evaluated at least 84 
one non-pharmacological intervention for the treatment of OH in older people.  85 
We included any comparative study, either randomized or non-randomized clinical trials 86 
that investigated the effect of any non-pharmacological intervention in OH. Before-and-87 
after studies (BAS) or repeated measure study design where patients acted as their own 88 
controls were included. We excluded observational studies or BAS with historical controls.  89 
We included trials involving older people in which the mean age of participants was ≥65 90 
years. For the purpose of this review, OH was defined as a drop in systolic BP ≥20 mmHg 91 
and/or a diastolic BP ≥10 mmHg determined by either active standing or passive tilt test30. 92 
Though our initial plan was to include only supine to standing OH, due to a lack of eligible 93 
studies in older people, we later included studies that evaluated the effect of non-94 
pharmacological intervention in different positons, e.g. supine to seated or seated to 95 
standing.  96 
Types of interventions 97 
Our review focused on trials of non-pharmacological interventions administered either 98 
alone or in combination with other non-pharmacological interventions. Comparator 99 




interventions of active pharmacological and non-pharmacological treatments as this might 101 
not provide accurate efficacy data on the non-pharmacological interventions.  102 
Types of outcome measures 103 
We conducted an online Delphi survey involving international experts from the field of 104 
geriatric medicine in order to select the most important outcomes measures for this review. 105 
Two outcome measures that were ranked as 'critical' by the Delphi panel for OH were 106 
included as the main outcomes for this review. These were:  107 
 Outcome 1: Change is postural systolic BP drop (mmHg) from supine to standing 108 
 Outcome 2: Orthostatic symptoms measured using any validated method.  109 
Data collection and analysis 110 
Two reviewers independently screened the titles and abstracts, and selected potentially 111 
relevant review articles for full text review. From the included review articles, we identified 112 
eligible primary studies as per inclusion criteria and reference checking was performed to 113 
identify any additional eligible primary studies. After removing duplicates using reference 114 
manager software (Refworks®), two reviewers independently reviewed the full-text of the 115 
eligible primary studies for inclusion or exclusion. At each stage of screening and study 116 
selection, any disagreements were resolved by discussion and by consensus with the lead 117 
author wherever necessary.  Two reviewers independently extracted data using a study 118 





The methodological quality of each SR was assessed using AMSTAR (A Measurement Tool to 121 
Assess Reviews) instrument31. The risk of bias for all the included primary studies was 122 
evaluated using the Cochrane collaboration’s recommended risk of bias tool 32. Risk of bias 123 
was rated by two reviewers independently, resolving disagreements by discussion and by 124 
consensus with the lead author when required.  125 
The quality of evidence was assessed using the GRADE (Grading of Recommendations 126 
Assessments, Development and Evaluation) approach, which classifies evidence into four 127 
categories - high, moderate, low and very low33. PICO clinical questions were developed for 128 
each intervention and outcome, and authors completed grading assessment and summary 129 
of findings (SoF) using online software, GRADEpro®34.   130 
The treatment effect size and heterogeneity were assessed as described in the SENATOR-131 
ONTOP protocol29. Meta-analysis and forest plots were created where possible using the 132 
version 5.3 of RevMan® software when data from at least two primary studies could be 133 
combined. Each type of non-pharmacological intervention was evaluated separately and we 134 
chose the generic inverse variance statistical method. When there was not enough 135 
information reported on the paper for outcomes data, we contacted study authors by email. 136 
The size of the treatment effect was expressed as the mean difference between the 137 
intervention and control group. Narrative synthesis of the evidence was undertaken where 138 
meta-analysis was not possible. 139 
Results 140 
A total of 2037 articles were retrieved after removing duplicates. We excluded 2029 non-141 
relevant articles after screening titles and abstract, and eight systematic review articles 142 




review articles that did not meet inclusion criteria.  Our search did not identify articles in 144 
any language other than English. The study selection process is illustrated in the PRISMA 145 
flow diagram (Figure A1). 146 
Of the six review articles included, only one article was of high quality (AMSTAR score 8-11), 147 
three were of medium quality (scoring 4-7) and two were of low quality (scoring 0-3). The 148 
systematic review articles were heterogeneous, varied extensively in population and the 149 
intervention type. Three articles included pharmacological treatment for OH in addition to 150 
evaluating the non-pharmacological interventions.  151 
From the six review articles, we identified 64 primary studies for abstract screening. 152 
Following the full-text review of 30 eligible primary studies, we included 11 primary studies 153 
in the review (Figure A1). Studies were conducted in Europe, USA, Australia, Japan and 154 
Israel between 1999 and 2017. Of the 11 included studies, six were observational studies 155 
with BAS design and five were RCTs (4 crossover design and one open RCT).   156 
Study sample sizes ranged from 8 to 100 participants and took place in various settings 157 
including in-patient hospital wards, outpatient ambulatory departments, and community 158 
non-clinical areas (i.e. outside of hospital) and research laboratories. None of the studies 159 
reported sample size calculations. Studies included patients with various OH types 160 
(symptomatic, persistent OH, progressive OH) from various causes of OH. The definition and 161 
measurement of OH, and the outcomes reported varied considerably between studies. 162 
Characteristics of the included studies are detailed in Table 1.   163 
Our review identified seven different types of non-pharmacological interventions from 11 164 
studies - lower limb compression, abdominal compression, combination therapy of lower 165 




based resistance training (HBRT) and multi-component non-pharmacological intervention. 167 
Duration of interventions varied from one single time point assessment to a period of 8 168 
weeks. Studies very rarely reported adverse events due to interventions. Based on non-169 
pharmacological therapies that were identified in our review, we categorised the non-170 
pharmacological interventions into two broad categories, compression therapy and others 171 
(Table 2).  172 
Figure 1 shows the risk of bias assessment of individual studies Risk of bias of the included 173 
studies was high in general, not only for the observational studies, but also for the RCTs 174 
mainly due to the type of study design. Risk of bias across studies (Figure A2) showed that 175 
nearly 75% of the studies had non-random sequence generation and lack of allocation 176 
concealment. Many of the studies included in this review used either BAS or crossover study 177 
design where patients acted as their own control, which limited the blinding of participants. 178 
Selective reporting and other types of bias were common in around 50% of the studies. 179 
Effectiveness of non-pharmacological interventions.  180 
Meta-analysis was performed for two non-pharmacological interventions, lower limb and 181 
abdominal compression bandage.  182 
Outcome 1: Change is postural systolic BP drop (mmHg) from supine to seating/standing 183 
Meta-analysis was undertaken on three studies comparing lower limb compression with no 184 
lower limb compression in 131 participants acting as their own controls (Figure 2). There 185 
was a significant improvement with lower limb compression (MD -9.83 mmHg, 95% CI -186 




Three studies comparing abdominal compression with no abdominal compression on 50 188 
participants acting as their own controls were suitable for meta-analyses (Figure 3).This 189 
showed statistically significant benefit for abdominal compression therapy (MD -12.30 190 
mmHg, 95% CI -18.20, -6.39). 191 
One study35 of graduated elastic compression hosiery (GECH) showed short term benefits in 192 
improving symptoms of OH. Maximum mean (SD) SBP drop on standing with and without 193 
GECH was 24.5 (7.9) and 52.2 (4.4) mmHg, (p <0.005) respectively. Orthostatic dizziness was 194 
abolished in 7 out of 10 patients.  195 
One study36 investigated the combined treatment effect of lower limb and abdominal 196 
compression bandage. Initial lower limb compression showed improvement in orthostatic 197 
blood pressure on standing (10±5.56 vs 20±6.85 mmHg), but addition of an abdominal 198 
bandage showed no added benefit (10±6.17 vs 26 ±6.85 mmHg).   199 
One study37 evaluated the physiological effects of SHU at 6-inches for 6 weeks but results 200 
showed this was ineffective in improving blood pressure or symptoms.  201 
One study38 evaluated bolus water drinking where patients were asked to take 480 mL of 202 
tap water in less than 5 minutes. Seating to Standing SBP 35 minutes before and after bolus 203 
water drinking showed positive effect (83 ± 20 mmHg vs 114 ± 30 mmHg, p<0.01) in 204 
orthostatic blood pressure drop.  205 
One study39 investigated home-based resistance-training (HBRT), however the mean 206 
reduction in SBP drop from supine to standing (36.8±13.4 at week 1 vs 43.8± 3.4 mmHg at 207 




One study40 evaluated a twelve component non-pharmacological intervention including: 209 
increased dietary salt (10–20 g daily); five glasses (250 mL/glass) of water per day; elevated 210 
head of bed (10–15 cm); thigh-high 30 mmHg compression stockings; frequent small meals 211 
(6 per day); coffee/tea in the morning; no alcohol use; avoiding exposure to hot ambient 212 
temperatures; avoiding strenuous early morning activities, sitting on the side of the bed for 213 
30 seconds before rising in the morning; regular moderate intensity exercise (20 minutes 214 
three times a week) and avoiding prolonged standing. The multi-component intervention 215 
did not improve SBP on standing, though it quantitatively improved OH symptoms in 7 out 216 
of 17 participants.  217 
Outcome 2: Efficacy of non-pharmacological interventions in improving OH symptoms.  218 
Our review identified two studies that had reported orthostatic symptoms using a validated 219 
questionnaire. One study36 investigated the effect of lower limb compression stocking in 220 
reducing orthostatic symptoms using a 7-item Specific Symptom Scale Questionnaire for 221 
Orthostatic Intolerance (SSS-OI) questionnaire36. The baseline SSS-OI score of 35.2±12.1 222 
decreased to 22.5±11.3 (p=0.01) after 1 month therapy, indicating significant symptom 223 
improvement. Another study41 compared no abdominal compression with a conventional 224 
elastic abdominal binder in 13 patients with neurogenic OH and measured severity of OH 225 
symptoms using Orthostatic Symptoms Scale (OSS)41. Median baseline OSS score improved 226 
from 5.0 points to -0.5 points five minutes after standing with conventional elastic 227 
abdominal binder.  228 
Quality of Evidence GRADE quality assessment and summary of evidence 229 
GRADE quality assessment was very low for all the included studies primarily due to the 230 




Summary of Findings table’s for lower limb and abdominal compression therapy for 232 
outcome 1.  233 
Discussion 234 
This is the first review of systematic reviews to summarize the evidence based 235 
recommendations for the non-pharmacological treatment of OH in an older population. 236 
Even though our meta-analysis showed statistically significant benefit favouring lower limb 237 
and abdominal compression therapy for management of OH in older people, the quality of 238 
included studies was very poor. There was substantial clinical heterogeneity among the 239 
three studies included for lower limb compression bandage. Two studies assessed the 240 
preventive effect from supine to seated OH and one study evaluated the treatment effect 241 
using a tilt table study. The lower limb compression pressure varied from 30 to 60mmHg 242 
with different pressures applied at different sites in the limbs. Furthermore, treatment 243 
duration varied from 5 to 20 minutes. In terms of population characteristics, two studies 244 
included OH patients with no specific cause or OH due to various acute conditions and one 245 
study included patients with OH due to acute decompensated heart failure.  246 
Similar to lower limb compression, three studies that evaluated abdominal compression 247 
therapy showed large differences in the population included, variation in the abdominal 248 
compression pressure from 10 to 20 mmHg and in the definition and measurement of OH. 249 
Studies also failed to report information on the effect of OH after discontinuation of 250 
compression therapy. GRADE quality was therefore downgraded for both LL and abdominal 251 
compression therapy despite the meta-analysis showing positive effect size from the pooled 252 
estimate. Therefore, we cannot make strong recommendations for use of compression 253 




pharmacological interventions because the lack of reporting of potential adverse effects is a 255 
concern.  Our results and conclusions regarding the compression therapy are similar to 256 
those of Frith42. Interestingly, compression therapy has been recommended by two 257 
systematic reviews based on limited evidence but the authors recommended further studies 258 
due to lack of good quality evidence43,44. In addition, a recent study by Newton and Frith 259 
suggested disregarding compression therapy in the aging population45.  260 
Based on the present review, there is no recommendation for any other types of non-261 
pharmacological interventions in older people with OH as evidence was restricted to a single 262 
small and poor quality study for each. Although, combination treatment of sleeping head-up 263 
with fludrocortisone is frequently used for treating OH, this recommendation is mainly 264 
based on results from two studies which have included only younger people i.e. aged 64 265 
years or younger, and small sample sizes46,47. Guidelines indicate the quality of evidence for 266 
recommending SHU for OH is low48.  267 
Similar to the finding by Saedon et al5, we also observed from our review that OH definition, 268 
protocol for measuring orthostatic hypotension, and evaluation of postural symptoms 269 
varied greatly among studies. This is a most important factor to note as this might have 270 
potential impact on the detection of OH, and thereby efficacy of the interventions. In 271 
addition, some studies carried out OH measurements in the fasting state but many did not 272 
specify. Therefore, it is uncertain whether these studies evaluated for post-prandial 273 
hypotension, which is an important and different entity to be considered in the geriatric 274 
population.  275 




None of the included studies in our review reported adverse effects of non-pharmacological 277 
therapies except two studies which reported that increased fluid intake in OH people 278 
aggravated urinary incontinence and hyponatraemia resulting in confusion40 and more ankle 279 
oedema in the intervention arm of the study evaluating SHU37.  280 
Strengths and weaknesses of the review 281 
We used an international Delphi survey for selecting the most important outcome 282 
measures. We performed meta-analyses for lower limb and abdominal compression therapy 283 
after contacting authors which, to our knowledge, is the first review to synthesize evidence 284 
for the non-pharmacological treatment for OH in older people. Furthermore, the quality of 285 
the evidence was assessed systematically by applying the GRADE quality assessment tool. A 286 
limitation of our review is that it may have missed important trials that were published after 287 
the last systematic review was published. Our review was focused only on older people with 288 
OH. Therefore, it is possible that helpful interventions that have not been sufficiently tested 289 
in older people were missed. Almost all the studies excluded participants with recent 290 
changes in the prescribed therapy or reduced/discontinued vasoactive medications. 291 
However, the effects of medications on OH have not always been reported clearly, which is 292 
potentially important in multimorbid older people with polypharmacy. Usual measures of 293 
OH used in these studies may not be accurate to detect patients at risk49.  Also, the 294 
recommendations from this review might not be applicable to specific populations of 295 
patients such as those with OH due to autonomic failure or spinal cord injury. Our review 296 
does not consider compliance issues. This may be relevant as Schoffer et al. reported that 297 




compression stockings amongst the 12 non-pharmacological therapies that they had 299 
investigated40. 300 
Conclusions/implications 301 
Our review found that there is no strong evidence to recommend any of the non-302 
pharmacological therapies for the management of OH. Nevertheless, we make a weak 303 
recommendation based on very low quality evidence for lower limb compression and 304 
abdominal compression bandage in treating OH in older people. The results of this review 305 
also emphasized the necessity to standardize the method of measuring OH.  306 
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Figure legend 463 
Figure 1. Risk of bias summary for individual study. Red (-) = high risk of bias, green (+) = low 464 
risk of bias and yellow (?) = unclear risk of bias.  465 
Figure 2. Forest plot showing the meta-analysis of lower limb compression bandage. Note: 466 
Patients acted as their controls, therefore the total sample size is 131.  467 
Figure 3. Forest plot showing the meta-analysis of abdominal compression binder Note: 468 
Patients acted as their controls in all three studies, therefore the total sample size is 50.  469 
Figure A1. PRISMA flow diagram of study selection process. SCI: Spinal Cord Injury. 470 
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Table 2. GRADE Quality of evidence for the various non-pharmacological interventions.  
Intervention 
category 





Lower limb compression bandage 
 
3 Very low 
Abdominal compression 3 Very low 
Lower limb  combined with abdominal 
compression 
 
1 Very low 
Lower limb compression with graduated elastic 
compression hosiery  
1 Very low 
 
 
Others Sleeping-head-up at 6 inches 1 Very low 
Bolus water drinking (480ml of tap water in 
<5minutes) 
 
1 Very low 
Home-Based Resistance Training program 1 Very low 
Multi-component non-pharmacological 
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Figure 1. Risk of bias summary for individual studies. Red (-) = high risk of bias, green (+) = 491 






Figure 2. Forest plot showing the meta-analysis of lower limb compression bandage. Note: Patients acted as their controls, therefore the total 495 








Figure 3. Forest plot showing the meta-analysis of abdominal compression binder Note: Patients acted as their controls in all three studies, 501 
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effects of abdominal versus lower limb compression.  
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(include a list of medications most linked to OH), to help put this topic into context. 
 
We updated the introduction (lines 44-46 and line 56) and discussion (line 310) to 
provide information on the potential medications that commonly cause OH.  
 
4. Table 2 - just spell out lower limb everywhere instead of creating an abbreviation. 
 
We removed the abbreviation and have now spelled out as ‘lower limb’ 
 
5. The PRISMA flow diagram was blank, probably because you have a white font on a 
white background. 
 
We changed the font colour of the PRISMA diagram to ‘black’.  
 
6. Move Figures 1 and 2a to the appendix. 
 
We moved Figures 1 and 2a to the appendix and renamed as Figure A1 and Appendix A2 
respectively.  
 
7. Delete Appendices 1 and 2. 
 
We deleted the Appendices 1 and 2 and updated the appendices with new list of 
appendices.  
 
8. RE reviewer 2 comment 1 --no need to spend too much time on measurement, other 
than to acknowledge that it is important. 




Thank you for your feedback. We have indicated this in the discussion section (line 288) 




This is an excellent study. I concur with the conclusions. 
 
Thank you very much for providing such a great comment. We really appreciate your 




1. A very important topic, no doubt. Rightfully you have stated that as it is a review of 
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reviewer requests below. We have attempted to balance completeness with the Editor’s 
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2. Nevertheless, when we discuss orthostatic hypotension, there are several basics that 
need addressing. How was the BP taken: manual or digital? Were the readings are 1 
min, 3 mins or both, from supine to sitting or standing? 
 
We agree that some of the basic details around measurement can have an important 
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blood pressure measurements in Table 1. We now also include a general comment on 
the potential impact of these details on the results in the discussion (line 288).   
 
3. Was there a relation to meals? The topic of post-prandial hypotension is important 
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discussion section (line 292). 
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5. What was the duration of therapy for the compression devices? If it was 8 weeks, did 
the orthostasis tend to recur after discontinuing the compression therapy? 
 
On Line 264, we explain that duration of therapy ranged from 5 to 20 minutes only. 
Information on the effect after discontinuation is not available. We now add a comment 
in the discussion to alert readers to this important point (line 270).  
 
6. Was there an attempt to look at the influence of change in meals (less carbohydrates), 
admn. of caffeine (coffee) after meals and the basic salt intake. This important 
approach is briefly discussed (lines 230 to 238) and could be elaborated. 
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modulation of meals and salt intake. Based on the limited evidence base on older people 
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7. If water intake was a means, did you look at foot elevation during the day or at nite? 
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